Key Points
-
The IL-17/T helper type 17 (TH17) axis is a key mediator of renal tissue injury in models of renal immune-mediated disease
-
In patients with autoimmune kidney diseases, such as anti-neutrophil cytoplasmic antibody-associated glomerulonephritis or lupus nephritis, IL-17 serum levels correlate with disease activity; moreover, TH17 cells are abundant in kidneys of these patients
-
In experimental crescentic glomerulonephritis, intestinal TH17 cells can migrate into the kidney where they contribute to renal pathology
-
TH17 cells in the gut are induced by intestinal microbiota; microbial depletion with antibiotics reduces the renal TH17 response and tissue injury in experimental crescentic glomerulonephritis
-
IL-17 and IL-23-specific antibody treatment are remarkably effective in psoriasis, but their role in immune-mediated kidney disease has not been studied
Abstract
CD4+ T cells are important drivers of tissue damage in immune-mediated renal diseases, such as anti-glomerular basement membrane glomerulonephritis, anti-neutrophil cytoplasmic antibody-associated glomerulonephritis, and lupus nephritis. The discovery of a distinct, IL-17-producing CD4+ T-cell lineage termed T helper type 17 (TH17) cells has markedly advanced current understanding of the pathogenic mechanisms of organ-specific immunity and the pathways that lead to target organ damage. TH17 cells are characterized by the expression of the transcription factor RORγt, the production of the pro-inflammatory cytokines IL-17A, IL-17F, IL-22, and high expression of the chemokine receptor C-C-motif chemokine receptor 6 (CCR6). An emerging body of evidence from experimental models and human studies supports a key role for these cells in the development of renal damage, and has led to the identification of targets to inhibit the production of TH17 cells in the intestine, their migration, or their actions within the kidney. Here, we describe the identification, regulation, and function of TH17 cells and their associated pathways in immune-mediated kidney diseases, with a particular focus on the mechanisms underlying renal tissue injury. We also discuss the rationale for the translation of these findings into new therapeutic approaches in patients with autoimmune kidney disease.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
O'Shea, J. J. & Paul, W. E. Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098–1102 (2010).
Raphael, I., Nalawade, S., Eagar, T. N. & Forsthuber, T. G. T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 74, 5–17 (2015).
Ueno, H., Banchereau, J. & Vinuesa, C. G. Pathophysiology of T follicular helper cells in humans and mice. Nat. Immunol. 16, 142–152 (2015).
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. & Coffman, R. L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348–2357 (1986).
Park, H. et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6, 1133–1141 (2005).
Harrington, L. E. et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123–1132 (2005).
Ivanov, I. I. et al. The orphan nuclear receptor RORγt directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126, 1121–1133 (2006).
Nurieva, R. et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448, 480–483 (2007).
Cua, D. J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744–748 (2003).
Gaffen, S. L., Jain, R., Garg, A. V. & Cua, D. J. The IL-23–IL-17 immune axis: from mechanisms to therapeutic testing. Nat. Rev. Immunol. 14, 585–600 (2014).
Murphy, C. A. et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198, 1951–1957 (2003).
Atarashi, K. et al. Th17 cell Induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367–380 (2015).
Ivanov, I. I. et al. Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009).
Yang, Y. et al. Focused specificity of intestinal TH17 cells towards commensal bacterial antigens. Nature 510, 152–156 (2014).
Codarri, L. et al. RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12, 560–567 (2011).
Zenewicz, L. A. et al. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27, 647–659 (2007).
Hirota, K. et al. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J. Exp. Med. 204, 2803–2812 (2007).
Acosta-Rodriguez, E. V. et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8, 639–646 (2007).
Burkett, P. R., Meyer zu Horste, G. & Kuchroo, V. K. Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J. Clin. Invest. 125, 2211–2219 (2015).
Iezzi, G. et al. CD40–CD40L cross-talk integrates strong antigenic signals and microbial stimuli to induce development of IL-17-producing CD4+ T cells. Proc. Natl Acad. Sci. USA 106, 876–881 (2009).
Mease, P. J. et al. Secukinumab inhibition of interleukin-17A in patients with psoriatic arthritis. N. Engl. J. Med. 373, 1329–1339 (2015).
Gordon, K. B. et al. Phase 3 trials of ixekizumab in moderate-to-severe plaque psoriasis. N. Engl. J. Med. 375, 345–356 (2016).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT03129100 (2017).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01965132 (2017).
Patel, D. D. & Kuchroo, V. K. Th17 cell pathway in human immunity: lessons from genetics and therapeutic interventions. Immunity 43, 1040–1051 (2015).
Van Kooten, C. et al. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J. Am. Soc. Nephrol. 9, 1526–1534 (1998).
Woltman, A. M. et al. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J. Am. Soc. Nephrol. 11, 2044–2055 (2000).
Strehlau, J. et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc. Natl Acad. Sci. USA 94, 695–700 (1997).
Dong, X., Bachman, L. A., Miller, M. N., Nath, K. A. & Griffin, M. D. Dendritic cells facilitate accumulation of IL-17 T cells in the kidney following acute renal obstruction. Kidney Int. 74, 1294–1309 (2008).
Paust, H. J. et al. The IL-23/Th17 axis contributes to renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 969–979 (2009).
Ooi, J. D., Phoon, R. K., Holdsworth, S. R. & Kitching, A. R. IL-23, not IL-12, directs autoimmunity to the Goodpasture antigen. J. Am. Soc. Nephrol. 20, 980–989 (2009).
Steinmetz, O. M. et al. The Th17-defining transcription factor RORγt promotes glomerulonephritis. J. Am. Soc. Nephrol. 22, 472–483 (2011).
Summers, S. A. et al. Th1 and Th17 cells induce proliferative glomerulonephritis. J. Am. Soc. Nephrol. 20, 2518–2524 (2009).
Tulone, C., Giorgini, A., Freeley, S., Coughlan, A. & Robson, M. G. Transferred antigen-specific TH17 but not TH1 cells induce crescentic glomerulonephritis in mice. Am. J. Pathol. 179, 2683–2690 (2011).
Hunemorder, S. et al. TH1 and TH17 cells promote crescent formation in experimental autoimmune glomerulonephritis. J. Pathol. 237, 62–71 (2015).
Ramani, K. et al. An essential role of interleukin-17 receptor signaling in the development of autoimmune glomerulonephritis. J. Leukoc. Biol. 96, 463–472 (2014).
Pisitkun, P. et al. Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis. Immunity 37, 1104–1115 (2012).
Paust, H. J. et al. Chemokines play a critical role in the cross-regulation of Th1 and Th17 immune responses in murine crescentic glomerulonephritis. Kidney Int. 82, 72–83 (2012).
Krebs, C. F. et al. MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN. J. Am. Soc. Nephrol. 24, 1955–1965 (2013).
Zhang, R. et al. Regulation of pathogenic Th17 cell differentiation by IL-10 in the development of glomerulonephritis. Am. J. Pathol. 183, 402–412 (2013).
Lee, H. et al. Cln 3-requiring 9 is a negative regulator of Th17 pathway-driven inflammation in anti-glomerular basement membrane glomerulonephritis. Am. J. Physiol. Renal Physiol. 311, F505–F519 (2016).
Jennette, J. C. & Falk, R. J. Small-vessel vasculitis. N. Engl. J. Med. 337, 1512–1523 (1997).
Gan, P. Y. et al. Th17 cells promote autoimmune anti-myeloperoxidase glomerulonephritis. J. Am. Soc. Nephrol. 21, 925–931 (2010).
Summers, S. A. et al. Toll-like receptor 2 induces Th17 myeloperoxidase autoimmunity while Toll-like receptor 9 drives Th1 autoimmunity in murine vasculitis. Arthritis Rheum. 63, 1124–1135 (2011).
Chavele, K. M. et al. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation. Arthritis Rheum. 62, 1539–1548 (2010).
Ludviksson, B. R. et al. Active Wegener's granulomatosis is associated with HLA-DR+ CD4+ T cells exhibiting an unbalanced Th1-type T cell cytokine pattern: reversal with IL-10. J. Immunol. 160, 3602–3609 (1998).
Abdulahad, W. H., Stegeman, C. A., Limburg, P. C. & Kallenberg, C. G. Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission. Arthritis Rheum. 58, 2196–2205 (2008).
Saito, H., Tsurikisawa, N., Tsuburai, T., Oshikata, C. & Akiyama, K. Cytokine production profile of CD4+ T cells from patients with active Churg–Strauss syndrome tends toward Th17. Int. Arch. Allergy Immunol. 149 (Suppl. 1), 61–65 (2009).
Nogueira, E. et al. Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis. Nephrol. Dial. Transplant. 25, 2209–2217 (2010).
Wilde, B. et al. Th17 expansion in granulomatosis with polyangiitis (Wegener's): the role of disease activity, immune regulation and therapy. Arthritis Res. Ther. 14, R227 (2012).
Rani, L. et al. Predominance of PR3 specific immune response and skewed TH17 versus T-regulatory milieu in active granulomatosis with polyangiitis. Cytokine 71, 261–267 (2015).
Krebs, C. F. et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078–1092 (2016).
Bomback, A. S. & Appel, G. B. Updates on the treatment of lupus nephritis. J. Am. Soc. Nephrol. 21, 2028–2035 (2010).
Weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J. Am. Soc. Nephrol. 15, 241–250 (2004).
Okamoto, A., Fujio, K., Tsuno, N. H., Takahashi, K. & Yamamoto, K. Kidney-infiltrating CD4+ T-cell clones promote nephritis in lupus-prone mice. Kidney Int. 82, 969–979 (2012).
Steinmetz, O. M. et al. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis. J. Immunol. 183, 4693–4704 (2009).
Zhang, Z., Kyttaris, V. C. & Tsokos, G. C. The role of IL-23/IL-17 axis in lupus nephritis. J. Immunol. 183, 3160–3169 (2009).
Haas, C., Ryffel, B. & Le Hir, M. IFN-γ is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice. J. Immunol. 158, 5484–5491 (1997).
Kikawada, E., Lenda, D. M. & Kelley, V. R. IL-12 deficiency in MRL-Fas(lpr) mice delays nephritis and intrarenal IFN-γ expression, and diminishes systemic pathology. J. Immunol. 170, 3915–3925 (2003).
Schmidt, T. et al. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol. 67, 475–487 (2015).
Crispin, J. C. et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181, 8761–8766 (2008).
Kyttaris, V. C., Zhang, Z., Kuchroo, V. K., Oukka, M. & Tsokos, G. C. Cutting edge: IL-23 receptor deficiency prevents the development of lupus nephritis in C57BL/6-lpr/lpr mice. J. Immunol. 184, 4605–4609 (2010).
Summers, S. A. et al. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane. Clin. Exp. Immunol. 176, 341–350 (2014).
Amarilyo, G., Lourenco, E. V., Shi, F. D. & La Cava, A. IL-17 promotes murine lupus. J. Immunol. 193, 540–543 (2014).
Riedel, J. H. et al. IL-17F promotes tissue injury in autoimmune kidney diseases. J. Am. Soc. Nephrol. 27, 3666–3677 (2016).
Kluger, M. A. et al. Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus. Kidney Int. 89, 158–166 (2016).
Wong, C. K., Ho, C. Y., Li, E. K. & Lam, C. W. Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 9, 589–593 (2000).
Wong, C. K. et al. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127, 385–393 (2008).
Doreau, A. et al. Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus. Nat. Immunol. 10, 778–785 (2009).
Yang, J. et al. Th17 and natural Treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum. 60, 1472–1483 (2009).
Abdel Galil, S. M., Ezzeldin, N. & El-Boshy, M. E. The role of serum IL-17 and IL-6 as biomarkers of disease activity and predictors of remission in patients with lupus nephritis. Cytokine 76, 280–287 (2015).
Zhao, X. F. et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol. Biol. Rep. 37, 81–85 (2010).
Koga, T. et al. Calcium/calmodulin-dependent kinase iv facilitates the recruitment of interleukin-17-producing cells to target organs through the CCR6/CCL20 axis in Th17 cell-driven inflammatory diseases. Arthritis Rheumatol. 68, 1981–1988 (2016).
Turner, J. E. et al. CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis. J. Am. Soc. Nephrol. 21, 974–985 (2010).
Odobasic, D. et al. Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice. Am. J. Pathol. 179, 1188–1198 (2011).
Disteldorf, E. M. et al. CXCL5 drives neutrophil recruitment in TH17-mediated GN. J. Am. Soc. Nephrol. 26, 55–66 (2015).
Petermann, F. et al. γδ T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33, 351–363 (2010).
Michel, M. L. et al. Identification of an IL-17-producing NK1.1neg iNKT cell population involved in airway neutrophilia. J. Exp. Med. 204, 995–1001 (2007).
Kim, H. Y. et al. Interleukin-17-producing innate lymphoid cells and the NLRP3 inflammasome facilitate obesity-associated airway hyperreactivity. Nat. Med. 20, 54–61 (2014).
Kluger, M. A. et al. RORγt+Foxp3+ cells are an independent bifunctional regulatory T cell lineage and mediate crescentic GN. J. Am. Soc. Nephrol. 27, 454–465 (2016).
Li, L. et al. IL-17 produced by neutrophils regulates IFN-γ-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J. Clin. Invest. 120, 331–342 (2010).
Fan, X. & Rudensky, A. Y. Hallmarks of tissue-resident lymphocytes. Cell 164, 1198–1211 (2016).
Turner, J. E. et al. IL-17A production by renal γδ T cells promotes kidney injury in crescentic GN. J. Am. Soc. Nephrol. 23, 1486–1495 (2012).
Riedel, J. H. et al. IL-33-mediated expansion of type 2 innate lymphoid cells protects from progressive glomerulosclerosis. J. Am. Soc. Nephrol. 28, 2068–2080 (2017).
Velden, J. et al. Renal IL-17 expression in human ANCA-associated glomerulonephritis. Am. J. Physiol. Renal Physiol. 302, F1663–F1673 (2012).
Ghali, J. R., O'Sullivan, K. M., Eggenhuizen, P. J., Holdsworth, S. R. & Kitching, A. R. Interleukin-17RA promotes humoral responses and glomerular injury in experimental rapidly progressive glomerulonephritis. Nephron 135, 207–223 (2017).
Haak, S. et al. IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J. Clin. Invest. 119, 61–69 (2009).
Wolf, D. et al. CD4+CD25+ regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol. 16, 1360–1370 (2005).
Paust, H. J. et al. Regulatory T cells control the Th1 immune response in murine crescentic glomerulonephritis. Kidney Int. 80, 154–164 (2011).
Ostmann, A. et al. Regulatory T cell-derived IL-10 ameliorates crescentic GN. J. Am. Soc. Nephrol. 24, 930–942 (2013).
Steinmetz, O. M., Turner, J. E. & Panzer, U. Staying on top of things right from the start: the obsessive–compulsive disorder of regulatory T cells. J. Am. Soc. Nephrol. 21, 6–7 (2010).
Josefowicz, S. Z. & Rudensky, A. Control of regulatory T cell lineage commitment and maintenance. Immunity 30, 616–625 (2009).
Chaudhry, A. et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science 326, 986–991 (2009).
Kluger, M. A. et al. Stat3 programs Th17-specific regulatory T cells to control GN. J. Am. Soc. Nephrol. 25, 1291–1302 (2014).
Brucklacher-Waldert, V., Carr, E. J., Linterman, M. A. & Veldhoen, M. Cellular plasticity of CD4+ T cells in the intestine. Front. Immunol. 5, 488 (2014).
Bending, D. et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119, 565–572 (2009).
Harbour, S. N., Maynard, C. L., Zindl, C. L., Schoeb, T. R. & Weaver, C. T. Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis. Proc. Natl Acad. Sci. USA 112, 7061–7066 (2015).
Jager, A., Dardalhon, V., Sobel, R. A., Bettelli, E. & Kuchroo, V. K. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169–7177 (2009).
Koenen, H. J. et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340–2352 (2008).
Lee, Y. K. et al. Late developmental plasticity in the T helper 17 lineage. Immunity 30, 92–107 (2009).
Lohning, M. et al. Long-lived virus-reactive memory T cells generated from purified cytokine-secreting T helper type 1 and type 2 effectors. J. Exp. Med. 205, 53–61 (2008).
Luthje, K. et al. The development and fate of follicular helper T cells defined by an IL-21 reporter mouse. Nat. Immunol. 13, 491–498 (2012).
Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44–56 (2008).
Hirota, K. et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12, 255–263 (2011).
Hirota, K. et al. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 14, 372–379 (2013).
Gagliani, N. et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221–225 (2015).
Krebs, C. F. et al. Plasticity of Th17 cells in autoimmune kidney diseases. J. Immunol. 197, 449–457 (2016).
Esplugues, E. et al. Control of TH17 cells occurs in the small intestine. Nature 475, 514–518 (2011).
Pelczar, P. et al. A pathogenic role for T cell-derived IL-22BP in inflammatory bowel disease. Science 354, 358–362 (2016).
Cosmi, L. et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205, 1903–1916 (2008).
Sano, T. et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163, 381–393 (2015).
Ivanov, I. I. et al. Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine. Cell Host Microbe 4, 337–349 (2008).
Lee, Y. K., Menezes, J. S., Umesaki, Y. & Mazmanian, S. K. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis. Proc. Natl Acad. Sci. USA 108 (Suppl. 1), 4615–4622 (2011).
Wu, H. J. et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 32, 815–827 (2010).
Chen, M. & Kallenberg, C. G. The environment, geoepidemiology and ANCA-associated vasculitides Autoimmun. Rev. 9, A293–A298 (2010).
Stegeman, C. A. et al. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann. Intern. Med. 120, 12–17 (1994).
Salmela, A. et al. Chronic nasal Staphylococcus aureus carriage identifies a subset of newly diagnosed granulomatosis with polyangiitis patients with high relapse rate. Rheumatology (Oxford) 56, 965–972 (2017).
Stegeman, C. A., Tervaert, J. W., de Jong, P. E. & Kallenberg, C. G. Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N. Engl. J. Med. 335, 16–20 (1996).
Peng, Z. et al. Increased number of Th22 cells and correlation with Th17 cells in peripheral blood of patients with IgA nephropathy. Hum. Immunol. 74, 1586–1591 (2013).
Rosenkranz, A. R. et al. Regulatory interactions of αβ and γδ T cells in glomerulonephritis. Kidney Int. 58, 1055–1066 (2000).
Falk, M. C. et al. Infiltration of the kidney by αβ and γδ T cells: effect on progression in IgA nephropathy. Kidney Int. 47, 177–185 (1995).
Riedel, J. H. et al. Immature renal dendritic cells recruit regulatory CXCR6+ invariant natural killer T cells to attenuate crescentic GN. J. Am. Soc. Nephrol. 23, 1987–2000 (2012).
Acknowledgements
We apologize to all colleagues whose work could not be cited or discussed in greater detail due to space restrictions. Our work described in this Review was supported by grants from the Deutsche Forschungsgemeinschaft (SFB 1192: to C.F.K. and U.P.), and grants from the Deutsche Nierenstiftung and Deutsche Gesellschaft für Nephrologie to C.F.K. We thank Oliver M. Steinmetz and Jan-Eric Turner, Universitätsklinikum Hamburg-Eppendorf, for critical reading of the manuscript before submission.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to researching data for the article, discussion of the content, and writing the article. C.F.K. and U.P. revised and/or edited the manuscript before submission.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Glossary
- T regulatory (Treg) cells
-
An immunosuppressive T-cell subset that controls the inflammatory reaction. Distinct subsets of Treg cells have been identified (for example, Foxp3+ Treg cells and FoxP3−IL-10+ type 1 Treg (TR1) cells)
- T follicular helper (TFH) cells
-
A subset of CD4+ T cells that facilitate B-cell activation in the germinal centre and the differentiation of long-lived plasma cells
- Delayed type hypersensitivity
-
(DTH). DTH or type IV hypersensitivity is a form of T cell-mediated immune reaction that is triggered by antigen in the skin and appears hours to days after antigen challenge.
- γδ T cells
-
A subset of T cells that develop in the thymus and express a γδ heterodimeric T-cell receptor. These cells have more innate-like functions than do conventional αβ T cells.
- Peyer's patches
-
A structure localized in the intestinal wall that consists of organized lymphoid follicles. As a part of the gut associated lymphoid tissue (GALT) they contribute to homeostasis at sites of food-derived antigens and microbiota.
- Nanobody
-
A single-domain antibody derived from camelid heavy chain antibodies that is 10-fold smaller than conventional antibodies.
Rights and permissions
About this article
Cite this article
Krebs, C., Schmidt, T., Riedel, JH. et al. T helper type 17 cells in immune-mediated glomerular disease. Nat Rev Nephrol 13, 647–659 (2017). https://doi.org/10.1038/nrneph.2017.112
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrneph.2017.112
This article is cited by
-
Kidney double positive T cells have distinct characteristics in normal and diseased kidneys
Scientific Reports (2024)
-
IL-23/IL-17 in a Paradoxical Association with Primary Membranous Nephropathy
Inflammation (2024)
-
Sequential administration of paricalcitol followed by IL-17 blockade for progressive refractory IgA nephropathy patients
Scientific Reports (2024)
-
IKK1 aggravates ischemia–reperfusion kidney injury by promoting the differentiation of effector T cells
Cellular and Molecular Life Sciences (2023)
-
A bifunctional fusion protein protected against diabetic nephropathy by suppressing NLRP3 activation
Applied Microbiology and Biotechnology (2023)